Cancer researchers at Georgetown University's Lombardi Comprehensive Cancer Center have successfully tested a small, engineered antibody they say shuts down growth of human glioblastoma tumors in cell and animal studies. Glioblastoma is the deadliest of brain cancers; there is no effective treatment.
Full article >>
Friday, July 31, 2009
Antibody targeting of glioblastoma shows promise in preclinical tests
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment